The global Anti-Peptic Ulcer Drugs revenue was US$ 8713 million in 2022 and is forecast to a readjusted size of US$ 21220 million by 2029 with a CAGR of 13.4% during the review period (2023-2029).

and India Anti-Peptic Ulcer Drugs Market

Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.

In India, the Anti-Peptic Ulcer Drugs revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period 2023-2029.

Global Anti-Peptic Ulcer Drugs key players include AstraZeneca, Ask-pharm, Takeda, Yangtze River Pharm, Shandong Luoxin, etc. Global top five players hold a share about 50%.

In terms of product, the segment includes Proton Pump Inhibitors (PPIs), Potassium-Competitive Acid Blockers (P-CAB), Antacids, H2 Antagonists, Ulcer Protective Drugs. And in terms of application, the application includes Gastritis, Gastric Ulcers, Duodenal Ulcers, Gastroesophageal Reflux Disease (GERD).

This report focuses on global and India Anti-Peptic Ulcer Drugs market, also covers the segmentation data of other regions in regional level and county level.

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for Anti-Peptic Ulcer Drugs will continue to grow rapidly in the future.

Global Anti-Peptic Ulcer Drugs Scope and Market Size

Anti-Peptic Ulcer Drugs market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Anti-Peptic Ulcer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.

For India market, this report focuses on the Anti-Peptic Ulcer Drugs market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Anti-Peptic Ulcer Drugs Market Report

Report Metric	Details
Report Name	and India Anti-Peptic Ulcer Drugs Market
Forecasted market size in 2029	US$ 21220 million
CAGR	13.4%
Forecasted years	2023 - 2029
Segment by Type	Proton Pump Inhibitors (PPIs) Potassium-Competitive Acid Blockers (P-CAB) Antacids H2 Antagonists Ulcer Protective Drugs
Segment by Application	Gastritis Gastric Ulcers Duodenal Ulcers Gastroesophageal Reflux Disease (GERD)
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, Ask-pharm, Takeda, Yangtze River Pharm, Shandong Luoxin, Huadong Medicine, Changzhou Siyao, Beijing Yuekang, Guangdong Dahua, Xian Janssen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Anti-Peptic Ulcer Drugs Market size in 2029?

Ans: The and India Anti-Peptic Ulcer Drugs Market size in 2029 will be US$ 21220 million.

What is the market share of major companies in and India Anti-Peptic Ulcer Drugs Market?

Ans: Global top five players hold a share about 50%.

What is the and India Anti-Peptic Ulcer Drugs Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Anti-Peptic Ulcer Drugs Market report?

Ans: The main players in the and India Anti-Peptic Ulcer Drugs Market are AstraZeneca, Ask-pharm, Takeda, Yangtze River Pharm, Shandong Luoxin, Huadong Medicine, Changzhou Siyao, Beijing Yuekang, Guangdong Dahua, Xian Janssen

What are the Application segmentation covered in the and India Anti-Peptic Ulcer Drugs Market report?

Ans: The Applications covered in the and India Anti-Peptic Ulcer Drugs Market report are Gastritis, Gastric Ulcers, Duodenal Ulcers, Gastroesophageal Reflux Disease (GERD)

What are the Type segmentation covered in the and India Anti-Peptic Ulcer Drugs Market report?

Ans: The Types covered in the and India Anti-Peptic Ulcer Drugs Market report are Proton Pump Inhibitors (PPIs), Potassium-Competitive Acid Blockers (P-CAB), Antacids, H2 Antagonists, Ulcer Protective Drugs

1 Study Coverage

1.1 Anti-Peptic Ulcer Drugs Product Introduction

1.2 Global Anti-Peptic Ulcer Drugs Outlook 2018 VS 2022 VS 2029

1.2.1 Global Anti-Peptic Ulcer Drugs Market Size for the Year 2018-2029

1.2.2 India Anti-Peptic Ulcer Drugs Market Size for the Year 2018-2029

1.3 Anti-Peptic Ulcer Drugs Market Size, India VS Global, 2018 VS 2022 VS 2029

1.3.1 The Market Share of India Anti-Peptic Ulcer Drugs in Global, 2018 VS 2022 VS 2029

1.3.2 The Growth Rate of Anti-Peptic Ulcer Drugs Market Size, India VS Global, 2018 VS 2022 VS 2029

1.4 Anti-Peptic Ulcer Drugs Market Dynamics

1.4.1 Anti-Peptic Ulcer Drugs Industry Trends

1.4.2 Anti-Peptic Ulcer Drugs Market Drivers

1.4.3 Anti-Peptic Ulcer Drugs Market Challenges

1.4.4 Anti-Peptic Ulcer Drugs Market Restraints

1.5 Assumptions and Limitations

1.6 Study Objectives

1.7 Years Considered

2 Anti-Peptic Ulcer Drugs by Type

2.1 Anti-Peptic Ulcer Drugs Market Segment by Type

2.1.1 Proton Pump Inhibitors (PPIs)

2.1.2 Potassium-Competitive Acid Blockers (P-CAB)

2.1.3 Antacids

2.1.4 H2 Antagonists

2.1.5 Ulcer Protective Drugs

2.2 Global Anti-Peptic Ulcer Drugs Market Size by Type (2018, 2022 & 2029)

2.3 Global Anti-Peptic Ulcer Drugs Market Size by Type (2018-2029)

2.4 India Anti-Peptic Ulcer Drugs Market Size by Type (2018, 2022 & 2029)

2.5 India Anti-Peptic Ulcer Drugs Market Size by Type (2018-2029)

3 Anti-Peptic Ulcer Drugs by Application

3.1 Anti-Peptic Ulcer Drugs Market Segment by Application

3.1.1 Gastritis

3.1.2 Gastric Ulcers

3.1.3 Duodenal Ulcers

3.1.4 Gastroesophageal Reflux Disease (GERD)

3.2 Global Anti-Peptic Ulcer Drugs Market Size by Application (2018, 2022 & 2029)

3.3 Global Anti-Peptic Ulcer Drugs Market Size by Application (2018-2029)

3.4 India Anti-Peptic Ulcer Drugs Market Size by Application (2018, 2022 & 2029)

3.5 India Anti-Peptic Ulcer Drugs Market Size by Application (2018-2029)

4 Global Anti-Peptic Ulcer Drugs Competitor Landscape by Company

4.1 Global Anti-Peptic Ulcer Drugs Market Size by Company

4.1.1 Global Key Companies of Anti-Peptic Ulcer Drugs, Ranked by Revenue (2022)

4.1.2 Global Anti-Peptic Ulcer Drugs Revenue by Player (2018-2023)

4.2 Global Anti-Peptic Ulcer Drugs Concentration Ratio (CR)

4.2.1 Anti-Peptic Ulcer Drugs Market Concentration Ratio (CR) (2018-2023)

4.2.2 Global Top 5 and Top 10 Largest Companies of Anti-Peptic Ulcer Drugs in 2022

4.2.3 Global Anti-Peptic Ulcer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Players of Anti-Peptic Ulcer Drugs Head office and Area Served

4.4 Global Key Players of Anti-Peptic Ulcer Drugs, Product and Application

4.5 Global Key Players of Anti-Peptic Ulcer Drugs, Date of Enter into This Industry

4.6 Companies Mergers & Acquisitions, Expansion Plans

4.7 India Anti-Peptic Ulcer Drugs Market Size by Company

4.7.1 Key Players of Anti-Peptic Ulcer Drugs in India, Ranked by Revenue (2022)

4.7.2 India Anti-Peptic Ulcer Drugs Revenue by Players (2021, 2022 & 2023)

5 Global Anti-Peptic Ulcer Drugs Market Size by Region

5.1 Global Anti-Peptic Ulcer Drugs Market Size by Region: 2018 VS 2022 VS 2029

5.2 Global Anti-Peptic Ulcer Drugs Market Size by Region (2018-2029)

5.2.1 Global Anti-Peptic Ulcer Drugs Market Size by Region: 2018-2023

5.2.2 Global Anti-Peptic Ulcer Drugs Market Size by Region (2024-2029)

6 Americas

6.1 Americas Anti-Peptic Ulcer Drugs Market Size YoY Growth 2018-2029

6.2 Americas Anti-Peptic Ulcer Drugs Market Size by Type

6.2.1 Americas Anti-Peptic Ulcer Drugs Market Size by Type (2018-2023)

6.2.2 Americas Anti-Peptic Ulcer Drugs Market Size by Type (2024-2029)

6.2.3 Americas Anti-Peptic Ulcer Drugs Market Share by Type (2018-2029)

6.3 Americas Anti-Peptic Ulcer Drugs Market Size by Application

6.3.1 Americas Anti-Peptic Ulcer Drugs Market Size by Application (2018-2023)

6.3.2 Americas Anti-Peptic Ulcer Drugs Market Size by Application (2024-2029)

6.3.3 Americas Anti-Peptic Ulcer Drugs Market Share by Application (2018-2029)

6.4 Americas Anti-Peptic Ulcer Drugs Market Facts & Figures by Country (2018, 2022 & 2029)

6.4.1 United States

6.4.2 Canada

6.4.3 Mexico

6.4.4 Brazil

7 EMEA

7.1 EMEA Anti-Peptic Ulcer Drugs Market Size YoY Growth 2018-2029

7.2 EMEA Anti-Peptic Ulcer Drugs Market Size by Type

7.2.1 EMEA Anti-Peptic Ulcer Drugs Market Size by Type (2018-2023)

7.2.2 EMEA Anti-Peptic Ulcer Drugs Market Size by Type (2024-2029)

7.2.3 EMEA Anti-Peptic Ulcer Drugs Market Share by Type (2018-2029)

7.3 EMEA Anti-Peptic Ulcer Drugs Market Size by Application

7.3.1 EMEA Anti-Peptic Ulcer Drugs Market Size by Application (2018-2023)

7.3.2 EMEA Anti-Peptic Ulcer Drugs Market Size by Application (2024-2029)

7.3.3 EMEA Anti-Peptic Ulcer Drugs Market Share by Application (2018-2029)

7.4 EMEA Anti-Peptic Ulcer Drugs Market Facts & Figures by Country (2018, 2022 & 2029)

7.4.1 Europe

7.4.2 Middle East

7.4.3 Africa

8 China

8.1 China Anti-Peptic Ulcer Drugs Market Size YoY Growth 2018-2029

8.2 China Anti-Peptic Ulcer Drugs Market Size by Type

8.2.1 China Anti-Peptic Ulcer Drugs Market Size by Type (2018-2023)

8.2.2 China Anti-Peptic Ulcer Drugs Market Size by Type (2024-2029)

8.2.3 China Anti-Peptic Ulcer Drugs Market Share by Type (2018-2029)

8.3 China Anti-Peptic Ulcer Drugs Market Size by Application

8.3.1 China Anti-Peptic Ulcer Drugs Market Size by Application (2018-2023)

8.3.2 China Anti-Peptic Ulcer Drugs Market Size by Application (2024-2029)

8.3.3 China Anti-Peptic Ulcer Drugs Market Share by Application (2018-2029)

9 APAC (excluding China)

9.1 APAC Anti-Peptic Ulcer Drugs Market Size YoY Growth 2018-2029

9.2 APAC Anti-Peptic Ulcer Drugs Market Size by Type

9.2.1 APAC Anti-Peptic Ulcer Drugs Market Size by Type (2018-2023)

9.2.2 APAC Anti-Peptic Ulcer Drugs Market Size by Type (2024-2029)

9.2.3 APAC Anti-Peptic Ulcer Drugs Market Share by Type (2018-2029)

9.3 APAC Anti-Peptic Ulcer Drugs Market Size by Application

9.3.1 APAC Anti-Peptic Ulcer Drugs Market Size by Application (2018-2023)

9.3.2 APAC Anti-Peptic Ulcer Drugs Market Size by Application (2024-2029)

9.3.3 APAC Anti-Peptic Ulcer Drugs Market Share by Application (2018-2029)

9.4 APAC Anti-Peptic Ulcer Drugs Market Facts & Figures by Country (2018, 2022 & 2029)

9.4.1 Japan

9.4.2 South Korea

9.4.3 China Taiwan

9.4.4 Southeast Asia

9.4.5 India

10 Key Players Profiles

10.1 AstraZeneca

10.1.1 AstraZeneca Company Details

10.1.2 AstraZeneca Business Overview

10.1.3 AstraZeneca Anti-Peptic Ulcer Drugs Introduction

10.1.4 AstraZeneca Revenue in Anti-Peptic Ulcer Drugs Business (2018-2023)

10.1.5 AstraZeneca Recent Development

10.2 Ask-pharm

10.2.1 Ask-pharm Company Details

10.2.2 Ask-pharm Business Overview

10.2.3 Ask-pharm Anti-Peptic Ulcer Drugs Introduction

10.2.4 Ask-pharm Revenue in Anti-Peptic Ulcer Drugs Business (2018-2023)

10.2.5 Ask-pharm Recent Development

10.3 Takeda

10.3.1 Takeda Company Details

10.3.2 Takeda Business Overview

10.3.3 Takeda Anti-Peptic Ulcer Drugs Introduction

10.3.4 Takeda Revenue in Anti-Peptic Ulcer Drugs Business (2018-2023)

10.3.5 Takeda Recent Development

10.4 Yangtze River Pharm

10.4.1 Yangtze River Pharm Company Details

10.4.2 Yangtze River Pharm Business Overview

10.4.3 Yangtze River Pharm Anti-Peptic Ulcer Drugs Introduction

10.4.4 Yangtze River Pharm Revenue in Anti-Peptic Ulcer Drugs Business (2018-2023)

10.4.5 Yangtze River Pharm Recent Development

10.5 Shandong Luoxin

10.5.1 Shandong Luoxin Company Details

10.5.2 Shandong Luoxin Business Overview

10.5.3 Shandong Luoxin Anti-Peptic Ulcer Drugs Introduction

10.5.4 Shandong Luoxin Revenue in Anti-Peptic Ulcer Drugs Business (2018-2023)

10.5.5 Shandong Luoxin Recent Development

10.6 Huadong Medicine

10.6.1 Huadong Medicine Company Details

10.6.2 Huadong Medicine Business Overview

10.6.3 Huadong Medicine Anti-Peptic Ulcer Drugs Introduction

10.6.4 Huadong Medicine Revenue in Anti-Peptic Ulcer Drugs Business (2018-2023)

10.6.5 Huadong Medicine Recent Development

10.7 Changzhou Siyao

10.7.1 Changzhou Siyao Company Details

10.7.2 Changzhou Siyao Business Overview

10.7.3 Changzhou Siyao Anti-Peptic Ulcer Drugs Introduction

10.7.4 Changzhou Siyao Revenue in Anti-Peptic Ulcer Drugs Business (2018-2023)

10.7.5 Changzhou Siyao Recent Development

10.8 Beijing Yuekang

10.8.1 Beijing Yuekang Company Details

10.8.2 Beijing Yuekang Business Overview

10.8.3 Beijing Yuekang Anti-Peptic Ulcer Drugs Introduction

10.8.4 Beijing Yuekang Revenue in Anti-Peptic Ulcer Drugs Business (2018-2023)

10.8.5 Beijing Yuekang Recent Development

10.9 Guangdong Dahua

10.9.1 Guangdong Dahua Company Details

10.9.2 Guangdong Dahua Business Overview

10.9.3 Guangdong Dahua Anti-Peptic Ulcer Drugs Introduction

10.9.4 Guangdong Dahua Revenue in Anti-Peptic Ulcer Drugs Business (2018-2023)

10.9.5 Guangdong Dahua Recent Development

10.10 Xian Janssen

10.10.1 Xian Janssen Company Details

10.10.2 Xian Janssen Business Overview

10.10.3 Xian Janssen Anti-Peptic Ulcer Drugs Introduction

10.10.4 Xian Janssen Revenue in Anti-Peptic Ulcer Drugs Business (2018-2023)

10.10.5 Xian Janssen Recent Development

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.2 Data Source

12.2 Disclaimer

12.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Anti-Peptic Ulcer Drugs Market Size India VS Global, CAGR (2018 VS 2022 VS 2029)

Table 2. Anti-Peptic Ulcer Drugs Market Trends

Table 3. Anti-Peptic Ulcer Drugs Market Drivers

Table 4. Anti-Peptic Ulcer Drugs Market Challenges

Table 5. Anti-Peptic Ulcer Drugs Market Restraints

Table 6. Global Anti-Peptic Ulcer Drugs Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 7. India Anti-Peptic Ulcer Drugs Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 8. Global Anti-Peptic Ulcer Drugs Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 9. India Anti-Peptic Ulcer Drugs Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 10. Global Key Companies of Anti-Peptic Ulcer Drugs, Ranked by Revenue (2022) & (US$ Million)

Table 11. Global Anti-Peptic Ulcer Drugs Revenue by Player, (US$ Million), 2018-2023

Table 12. Global Anti-Peptic Ulcer Drugs Revenue Share by Player, 2018-2023

Table 13. Global Anti-Peptic Ulcer Drugs Companies Market Concentration Ratio (CR5 and HHI)

Table 14. Global Anti-Peptic Ulcer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Peptic Ulcer Drugs as of 2022)

Table 15. Global Key Players of Anti-Peptic Ulcer Drugs, Headquarters and Area Served

Table 16. Global Key Players of Anti-Peptic Ulcer Drugs, Product and Application

Table 17. Global Key Players of Anti-Peptic Ulcer Drugs, Date of Enter into This Industry

Table 18. Companies Mergers & Acquisitions, Expansion Plans

Table 19. Key Players of Anti-Peptic Ulcer Drugs in India, Ranked by Revenue (2022) & (US$ Million)

Table 20. India Anti-Peptic Ulcer Drugs Revenue by Players, (US$ Million), 2021, 2022 & 2023

Table 21. India Anti-Peptic Ulcer Drugs Revenue Share by Players, 2021, 2022 & 2023

Table 22. Global Anti-Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 23. Global Anti-Peptic Ulcer Drugs Market Size by Region (2018-2023) & (US$ Million)

Table 24. Global Anti-Peptic Ulcer Drugs Market Size Forecast by Region (2024-2029) & (US$ Million)

Table 25. Americas Anti-Peptic Ulcer Drugs Market Size by Type (2018-2023) & (US$ Million)

Table 26. Americas Anti-Peptic Ulcer Drugs Market Size by Type (2024-2029) & (US$ Million)

Table 27. Americas Anti-Peptic Ulcer Drugs Market Size by Application (2018-2023) & (US$ Million)

Table 28. Americas Anti-Peptic Ulcer Drugs Market Size by Application (2024-2029) & (US$ Million)

Table 29. Americas Anti-Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 30. Americas Anti-Peptic Ulcer Drugs Market Size by Country (2018-2023) & (US$ Million)

Table 31. Americas Anti-Peptic Ulcer Drugs Market Size by Country (2024-2029) & (US$ Million)

Table 32. EMEA Anti-Peptic Ulcer Drugs Market Size by Type (2018-2023) & (US$ Million)

Table 33. EMEA Anti-Peptic Ulcer Drugs Market Size by Type (2024-2029) & (US$ Million)

Table 34. EMEA Anti-Peptic Ulcer Drugs Market Size by Application (2018-2023) & (US$ Million)

Table 35. EMEA Anti-Peptic Ulcer Drugs Market Size by Application (2024-2029) & (US$ Million)

Table 36. EMEA Anti-Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 37. EMEA Anti-Peptic Ulcer Drugs Market Size by Country (2018-2023) & (US$ Million)

Table 38. EMEA Anti-Peptic Ulcer Drugs Market Size by Country (2024-2029) & (US$ Million)

Table 39. China Anti-Peptic Ulcer Drugs Market Size by Type (2018-2023) & (US$ Million)

Table 40. China Anti-Peptic Ulcer Drugs Market Size by Type (2024-2029) & (US$ Million)

Table 41. China Anti-Peptic Ulcer Drugs Market Size by Application (2018-2023) & (US$ Million)

Table 42. China Anti-Peptic Ulcer Drugs Market Size by Application (2024-2029) & (US$ Million)

Table 43. China Anti-Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 44. APAC Anti-Peptic Ulcer Drugs Market Size by Type (2018-2023) & (US$ Million)

Table 45. APAC Anti-Peptic Ulcer Drugs Market Size by Type (2024-2029) & (US$ Million)

Table 46. APAC Anti-Peptic Ulcer Drugs Market Size by Application (2018-2023) & (US$ Million)

Table 47. APAC Anti-Peptic Ulcer Drugs Market Size by Application (2024-2029) & (US$ Million)

Table 48. APAC Anti-Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 49. APAC Anti-Peptic Ulcer Drugs Market Size by Region (2018-2023) & (US$ Million)

Table 50. APAC Anti-Peptic Ulcer Drugs Market Size by Region (2024-2029) & (US$ Million)

Table 51. AstraZeneca Company Details

Table 52. AstraZeneca Business Overview

Table 53. AstraZeneca Anti-Peptic Ulcer Drugs Product

Table 54. AstraZeneca Revenue in Anti-Peptic Ulcer Drugs Business (2018-2023) & (US$ Million)

Table 55. AstraZeneca Recent Development

Table 56. Ask-pharm Company Details

Table 57. Ask-pharm Business Overview

Table 58. Ask-pharm Anti-Peptic Ulcer Drugs Product

Table 59. Ask-pharm Revenue in Anti-Peptic Ulcer Drugs Business (2018-2023) & (US$ Million)

Table 60. Ask-pharm Recent Development

Table 61. Takeda Company Details

Table 62. Takeda Business Overview

Table 63. Takeda Anti-Peptic Ulcer Drugs Product

Table 64. Takeda Revenue in Anti-Peptic Ulcer Drugs Business (2018-2023) & (US$ Million)

Table 65. Takeda Recent Development

Table 66. Yangtze River Pharm Company Details

Table 67. Yangtze River Pharm Business Overview

Table 68. Yangtze River Pharm Anti-Peptic Ulcer Drugs Product

Table 69. Yangtze River Pharm Revenue in Anti-Peptic Ulcer Drugs Business (2018-2023) & (US$ Million)

Table 70. Yangtze River Pharm Recent Development

Table 71. Shandong Luoxin Company Details

Table 72. Shandong Luoxin Business Overview

Table 73. Shandong Luoxin Anti-Peptic Ulcer Drugs Product

Table 74. Shandong Luoxin Revenue in Anti-Peptic Ulcer Drugs Business (2018-2023) & (US$ Million)

Table 75. Shandong Luoxin Recent Development

Table 76. Huadong Medicine Company Details

Table 77. Huadong Medicine Business Overview

Table 78. Huadong Medicine Anti-Peptic Ulcer Drugs Product

Table 79. Huadong Medicine Revenue in Anti-Peptic Ulcer Drugs Business (2018-2023) & (US$ Million)

Table 80. Huadong Medicine Recent Development

Table 81. Changzhou Siyao Company Details

Table 82. Changzhou Siyao Business Overview

Table 83. Changzhou Siyao Anti-Peptic Ulcer Drugs Product

Table 84. Changzhou Siyao Revenue in Anti-Peptic Ulcer Drugs Business (2018-2023) & (US$ Million)

Table 85. Changzhou Siyao Recent Development

Table 86. Beijing Yuekang Company Details

Table 87. Beijing Yuekang Business Overview

Table 88. Beijing Yuekang Anti-Peptic Ulcer Drugs Product

Table 89. Beijing Yuekang Revenue in Anti-Peptic Ulcer Drugs Business (2018-2023) & (US$ Million)

Table 90. Beijing Yuekang Recent Development

Table 91. Guangdong Dahua Company Details

Table 92. Guangdong Dahua Business Overview

Table 93. Guangdong Dahua Anti-Peptic Ulcer Drugs Product

Table 94. Guangdong Dahua Revenue in Anti-Peptic Ulcer Drugs Business (2018-2023) & (US$ Million)

Table 95. Guangdong Dahua Recent Development

Table 96. Xian Janssen Company Details

Table 97. Xian Janssen Business Overview

Table 98. Xian Janssen Anti-Peptic Ulcer Drugs Product

Table 99. Xian Janssen Revenue in Anti-Peptic Ulcer Drugs Business (2018-2023) & (US$ Million)

Table 100. Xian Janssen Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Anti-Peptic Ulcer Drugs Product Picture

Figure 2. Global Anti-Peptic Ulcer Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Anti-Peptic Ulcer Drugs Market Size 2018-2029 (US$ Million)

Figure 4. India Anti-Peptic Ulcer Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 5. India Anti-Peptic Ulcer Drugs Market Size 2018-2029 (US$ Million)

Figure 6. India Anti-Peptic Ulcer Drugs Market Share in Global 2018-2029

Figure 7. Anti-Peptic Ulcer Drugs Report Years Considered

Figure 8. Product Picture of Proton Pump Inhibitors (PPIs)

Figure 9. Product Picture of Potassium-Competitive Acid Blockers (P-CAB)

Figure 10. Product Picture of Antacids

Figure 11. Product Picture of H2 Antagonists

Figure 12. Product Picture of Ulcer Protective Drugs

Figure 13. Global Anti-Peptic Ulcer Drugs Market Share by Type in 2022 & 2029

Figure 14. Global Anti-Peptic Ulcer Drugs Market Size by Type (2018-2029) & (US$ Million)

Figure 15. Global Anti-Peptic Ulcer Drugs Market Share by Type (2018-2029)

Figure 16. India Anti-Peptic Ulcer Drugs Market Share by Type in 2022 & 2029

Figure 17. India Anti-Peptic Ulcer Drugs Market Size by Type (2018-2029) & (US$ Million)

Figure 18. India Anti-Peptic Ulcer Drugs Market Share by Type (2018-2029)

Figure 19. Product Picture of Gastritis

Figure 20. Product Picture of Gastric Ulcers

Figure 21. Product Picture of Duodenal Ulcers

Figure 22. Product Picture of Gastroesophageal Reflux Disease (GERD)

Figure 23. Global Anti-Peptic Ulcer Drugs Market Share by Application in 2022 & 2029

Figure 24. Global Anti-Peptic Ulcer Drugs Market Size by Application (2018-2029) & (US$ Million)

Figure 25. Global Anti-Peptic Ulcer Drugs Market Share by Application (2018-2029)

Figure 26. India Anti-Peptic Ulcer Drugs Market Share by Application in 2022 & 2029

Figure 27. India Anti-Peptic Ulcer Drugs Market Size by Application (2018-2029) & (US$ Million)

Figure 28. India Anti-Peptic Ulcer Drugs Market Share by Application (2018-2029)

Figure 29. The Top 5 and 10 Largest Companies of Anti-Peptic Ulcer Drugs in the World: Market Share by Anti-Peptic Ulcer Drugs Revenue in 2022

Figure 30. Global Anti-Peptic Ulcer Drugs Market Size Market Share by Region: 2018 VS 2022 VS 2029

Figure 31. Global Anti-Peptic Ulcer Drugs Market Share by Region (2018-2029)

Figure 32. Americas Anti-Peptic Ulcer Drugs Market Size Growth Rate 2018-2029 (US$ Million)

Figure 33. Americas Anti-Peptic Ulcer Drugs Market Share by Type (2018-2029)

Figure 34. Americas Anti-Peptic Ulcer Drugs Market Share by Application (2018-2029)

Figure 35. United States Anti-Peptic Ulcer Drugs Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 36. Canada Anti-Peptic Ulcer Drugs Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 37. Mexico Anti-Peptic Ulcer Drugs Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 38. Brazil Anti-Peptic Ulcer Drugs Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 39. EMEA Anti-Peptic Ulcer Drugs Market Size Growth Rate 2018-2029 (US$ Million)

Figure 40. EMEA Anti-Peptic Ulcer Drugs Market Share by Type (2018-2029)

Figure 41. EMEA Anti-Peptic Ulcer Drugs Market Share by Application (2018-2029)

Figure 42. Europe Anti-Peptic Ulcer Drugs Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 43. Middle East Anti-Peptic Ulcer Drugs Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 44. Africa Anti-Peptic Ulcer Drugs Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 45. China Anti-Peptic Ulcer Drugs Market Size Growth Rate 2018-2029 (US$ Million)

Figure 46. China Anti-Peptic Ulcer Drugs Market Share by Type (2018-2029)

Figure 47. China Anti-Peptic Ulcer Drugs Market Share by Application (2018-2029)

Figure 48. APAC Anti-Peptic Ulcer Drugs Market Size Growth Rate 2018-2029 (US$ Million)

Figure 49. APAC Anti-Peptic Ulcer Drugs Market Share by Type (2018-2029)

Figure 50. APAC Anti-Peptic Ulcer Drugs Market Share by Application (2018-2029)

Figure 51. Japan Anti-Peptic Ulcer Drugs Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 52. South Korea Anti-Peptic Ulcer Drugs Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 53. China Taiwan Anti-Peptic Ulcer Drugs Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 54. Southeast Asia Anti-Peptic Ulcer Drugs Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 55. India Anti-Peptic Ulcer Drugs Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 56. AstraZeneca Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2018-2023)

Figure 57. Ask-pharm Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2018-2023)

Figure 58. Takeda Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2018-2023)

Figure 59. Yangtze River Pharm Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2018-2023)

Figure 60. Shandong Luoxin Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2018-2023)

Figure 61. Huadong Medicine Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2018-2023)

Figure 62. Changzhou Siyao Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2018-2023)

Figure 63. Beijing Yuekang Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2018-2023)

Figure 64. Guangdong Dahua Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2018-2023)

Figure 65. Xian Janssen Revenue Growth Rate in Anti-Peptic Ulcer Drugs Business (2018-2023)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions